The Download: cut through AI coding hype, and biotech trends to watch
Quote of the day “I am very annoyed. I’m very disappointed. I’m seriously frustrated.” —Pfizer CEO Albert Bourla tells attendees at a…
Tag
Quote of the day “I am very annoyed. I’m very disappointed. I’m seriously frustrated.” —Pfizer CEO Albert Bourla tells attendees at a…
Recently, embryo scoring has evolved. Labs can pinch off a couple of cells from an embryo, look at its DNA, and screen for some genetic…
PARIS — French flavor and fragrance supplier Mane Group has acquired Belgian biotech company ChemoSensoryx Biosciences. Financial terms of…
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Mainland retail traders are being lured by the outperformance of the city’s equities, combined with their accessibility and abundance of…
Novartis agreed to buy Tourmaline Bio in a deal valued at about US$1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to…
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds…
Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment Local biotech startup…
Biotech beauty company Debut has secured $20 million in investment to enhance its AI-driven ingredient discovery platform and expand its…
Funding focus is a new series analysing cash flow into the European tech ecosystem. After debuting with a look at the biggest rounds so…
The NATO Innovation Fund (NIF) has made its first investment in a biotechnology startup. The alliance’s VC arm announced today that it’s…
Danish biotech Cellugy has raised €8.1mn in EU funding to accelerate production of a biodegradable material designed to replace…
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping…
K has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday,…
LONDON— Sparxell, a Cambridge-based plant-based colorant start-up, has secured 1.9 million euros in funding from the European Innovation…
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and…
A federal jury has convicted the accused mastermind behind a murder-for-hire plot of all charges brought against him in the 2018 killing…
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant…
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central…
AT A time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical dealmaking has become…